Big Options Wins & More

Huge Options Success

Yesterday morning, we offered up a couple of fresh options ideas for our readers, and thanks to another solid day for the markets, along with the earnings-fueled activity of each of these plays, we were able to see gains of an immense nature on the day.

Our ideas were the ROK Weekly $195-200 Calls and the DXC Weekly $30-32 Calls. Regardless of which chain or strike point our readers latched onto, there were impressive multi-bag profit opportunities on the table, which were as follows:

ROK Weekly $195-200 Calls
$195 Calls – Range: 4.50-11.79 – Max Gain: 162%
$200 Calls – Range: 1.96-8.00 – Max Gain: 308%

DXC Weekly $30-32 Calls
$30 Calls – Range: 1.50-5.19 – Max Gain: 246%
$31 Calls – Range: 1.15-4.10 – Max Gain: 257%
$32 Calls – Range: .85-3.20 – Max Gain: 276%

_____

Fresh Ideas:
GOOS Weekly $40.50-42 Calls
LK 11/22 $19-21 Calls


Applied DNA Sciences, Inc. APDN

We also want to briefly go over yesterday’s landmark performance by APDN, a stock we most recently mentioned on October 22nd. We did see a backslide following that alert, but APDN has more than made up for it with its incredible move.

Yesterday alone, the stock made a big enough move to register as the number one gainer on the NASDAQ as it ran from 5.57-19.69, an eye-popping 254% pop.


Extended Watchlist:
DDOG, ONCY, SGLB, NAT, SPB, HMY, NBRV, CLVS

Blue Horseshoe Stocks: Prime Bottom Play

CarMax, Inc. KMX – Recap 

To open things up this week, we’re going to go over the performance of a fresh options ideas from Friday morning’s premarket report. We were tracking the  KMX Weekly $85-87.50 Calls and we met with some very good fortune in the form of multi-bag, single session gain opportunities.

All four of the contract sets we watching provided enormous intraday chances, which wasn’t surprising, given the huge help we had last week from a surge in the markets. A strong earnings report from KMX did the rest, and we finished out the week with these superb gains: 

$85 Calls – Range: .48-2.55 – Max Gain: 431%
$86 Calls – Range: .27-1.73 – Max Gain: 541%
$87 Calls – Range: .15-1.09 – Max Gain: 627%
$87.50 Calls – Range: .10-.76 – Max Gain: 660%

Fresh Ideas: 


Seres Therapeutics, Inc. MCRB 

We’re currently very interested in MCRB for multiple reasons. The stock recently touched down on a new annual low, and at the same time, a company director purchased a huge block of shares which amounted to a significant percentage of the overall market cap.

Since then the stock has been trending off of that bottom, with just the sort of volatility potential we’re always after. In addition to the stock itself being a solid candidate for a recovery play, we will also place the MCRB 07/19 $2.50 Calls on watch.


Extended Watchlist:
ACST, MEIP, VIVE, GSV, OBLN, BPMX, NBRV, CJJD

Blue Horseshoe Stocks: Earnings-Related Options Ideas

OPTIONS REVIEW

We closed out the short week on Thursday with a pair of last minute options ideas, and both of those provided our readers and ourselves with the opportunity to take significant intraday profits.

United Rentals Inc. URI Weekly $134-136 Calls
$134 Calls – Range:
1.65-4.20  – Max Gain: 155%
$135 Calls – Range: .91-3.50 – Max Gain: 285%
$136 Calls – Range:
.85-2.73  – Max Gain: 221%

Union Pacific Corp. UNP Weekly $172.50 & 175 Calls
$172.50 Calls – Range: 2.61-5.07  – Max Gain: 94%
$175 Calls – Range: .84-2.95 – Max Gain: 251%

______

EARNINGS RELATED OPTIONS IDEAS
Halliburton Co. HAL Weekly $31.50-32.50 Calls
Kimberly Clark Corp. KMB Weekly $125-128 Calls


Moleculin Biotech, Inc. MBRX – Recap

We highlighted this play at the end of last month, and shortly thereafter we would observe a low of .7772. Last week, MBRX reached a new high of 1.47, which translates to a gain of 89% in roughly three weeks’ time.

The move, which filled the entirety of the topside gap on the chart, was due to Thursday’s revelation that the company’s drug Annamycin had received the FDA’s Approval for fast-track designation. At 4:30PM on Wednesday, MBRX officials will conduct a call to discuss this and other developments on a live webcast, which will be available in the Investor Relations section at www.moleculin.com.


Extended Watchlist:
NBRV, TLGT, FCEL, UXIN, TENX, COMM, KEG, CEI,